Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial
{{output}}
Objective: To evaluate the efficacy, safety, and tolerability of combination therapy with intramuscular interferon beta-1a and oral doxycycline, a potent inhibitor of matrix metalloproteinases, in patients with relapsing-remittin... ...
